PCL201H1 Lecture : Lecture 27 Pharmacoeconomics

60 views3 pages
22 Apr 2012
School
Department
Course
Professor

Document Summary

Douglas pushed for socialized medicine; believed it was unethical to profit from sickness. Not covered: outpatient medications, most allied health, densitry, non-medically necessary surgery. Health expenditure per capita varies widely across countries. Drugs that do not require hospitalization save health care system. Increased regulation of new technology, assessment of economic impact, cost- effectiveness, cost-utility, trade-offs. Increased drug/technology expenditures: new products, more expensive products, more prescriptions/utilization for more patients. Finite funding envelope: limited money available, depends on taxes. Metastatic colon cancer: leading cause of cancer, tumor in colon, rectum, appendix, colorectal cancers arise from polyps in colon, commonly spreads to liver. Cetuximab: drug class; egfr inhibitor, +2 months survival. 1% population affected; auto-immune disease affects joints, skin, organs, cardiovascular system: treatment: disease modifying antirheumatic drug and anti-inflammatory agents, analgesics. Improved range of motion, slows disease progression, improves quality of life, remain in workforce.

Get access

Grade+20% off
$8 USD/m$10 USD/m
Billed $96 USD annually
Grade+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
40 Verified Answers
Class+
$8 USD/m
Billed $96 USD annually
Class+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
30 Verified Answers

Related Documents

Related Questions